An Open Label Assessment of the Effect of Coadministration of Posaconazole or Pantoprazole on Systemic Exposure of F901318 and the Effect of F901318 on the Single Dose Pharmacokinetics of Tacrolimus and Cyclosporine A in Healthy Male and Female Subjects

Trial Profile

An Open Label Assessment of the Effect of Coadministration of Posaconazole or Pantoprazole on Systemic Exposure of F901318 and the Effect of F901318 on the Single Dose Pharmacokinetics of Tacrolimus and Cyclosporine A in Healthy Male and Female Subjects

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 03 Nov 2017

At a glance

  • Drugs F 901318 (Primary) ; Ciclosporin; Pantoprazole; Posaconazole; Tacrolimus
  • Indications Aspergillosis
  • Focus Pharmacokinetics
  • Sponsors F2G
  • Most Recent Events

    • 30 Oct 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 31 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top